Abstract
Increased expression of endothelin receptor type B (ETBR), a vasoactive receptor, has recently been implied in the reduced cerebral blood flow and exacerbated neuronal damage after ischemia-reperfusion (I/R). The study explores the regulatory mechanisms of ETBR to identify drug targets to restore normal cerebral artery contractile function as part of successful neuroprotective therapy.
Original language | English |
---|---|
Article number | e113624 |
Journal | PLoS ONE |
Volume | 9 |
Issue number | 12 |
DOIs | |
Publication status | Published - 2014 |
Subject classification (UKÄ)
- Other Clinical Medicine